Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-T Meeting 2020 | The importance of post-authorization studies on CAR T-cells

Christian Chabannon • 1 Feb 2020
CAR-T Meeting 2020
General CAR-T

Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, discusses the need for extended follow-up after CAR T-cell therapy to obtain long term safety data. This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.

More from Christian Chabannon

1:41
The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon • 16 Apr 2024
2:17
Improving access to advanced therapies: the access to CAR-T in Europe
Christian Chabannon • 17 Feb 2024
1:33
Addressing the changing needs for ad-hoc resources for safe delivery of advanced therapies
Christian Chabannon • 17 Feb 2024
1:36
IFM-2015-03: plerixafor before salvage ASCT in R/R myeloma
Christian Chabannon • 21 Oct 2023

Related Videos

4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
1:41
The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals